Literature DB >> 6419710

The effect of prophylaxis for thrombosis on heterotopic ossification following total hip joint replacement.

R Eyb, K Knahr.   

Abstract

The effect of prophylaxis for thrombosis on heterotopic ossification was investigated using 216 total hip joint endoprostheses implanted between 1976 and 1978. During this period a random comparative study of low dose heparin and oxyphenbutazone/acetylsalycilic acid was carried out. The rate of ossification in the 216 hip joints was 17.6%, and was about average for the values specified in literature on this subject. Heterotopic ossification occurred in 30.1% of the 103 hip joints treated with heparin, whilst the rate of ossification in the 113 hip joints treated with oxyphenbutazone/acetylsalycilic acid was only 6.2%. This represents a statistically significant difference in disfavour of prophylaxis with heparin.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6419710     DOI： 10.1007/BF02498727

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN： 0344-8444


  18 in total

1.  Serum alkaline phosphatase in heterotopic para-articular ossification after total hip replacement.

Authors:  R A Mollan
Journal:  J Bone Joint Surg Br       Date:  1979-11

2.  [Additional information regarding periarticular ossifications after total hip replacement (author's transl)].

Authors:  A Eggert; H Seidel; J Ruhnke
Journal:  Arch Orthop Unfallchir       Date:  1977-03-31

3.  Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement.

Authors:  W H Harris; E W Salzman; C Athanasoulis; A C Waltman; S Baum; R W DeSanctis
Journal:  J Bone Joint Surg Am       Date:  1974-12       Impact factor: 5.284

4.  [Results of total hip replacement (control of the 1962--1968 operated cases)].

Authors:  R Safi; A Schreiber
Journal:  Z Orthop Ihre Grenzgeb       Date:  1972-02

5.  [Complications of hip alloarthroplasty with periarticular tissue reactions].

Authors:  H Cotta; K P Schulitz
Journal:  Arch Orthop Unfallchir       Date:  1970

6.  Acetylsalicylic acid in a trial to diminish thromboembolic complications after elective hip surgery.

Authors:  J Soreff; H Johnsson; L Diener; L Göransson
Journal:  Acta Orthop Scand       Date:  1975-05

7.  [Periarticular ossification following replacement of the hip-joint. Clinical and radiologic examination of 697 hip-joints (author's transl)].

Authors:  U Holz; F Kraner; S Weller
Journal:  Z Orthop Ihre Grenzgeb       Date:  1977-04

8.  [The pathological significance of paraarticular ossifications after total hip replacements (author's transl)].

Authors:  L Hanslik; H Radloff
Journal:  Arch Orthop Unfallchir       Date:  1974

9.  Ectopic ossification following total hip replacement. Incidence and a method of classification.

Authors:  A F Brooker; J W Bowerman; R A Robinson; L H Riley
Journal:  J Bone Joint Surg Am       Date:  1973-12       Impact factor: 5.284

10.  Treatment of periarticular calcification after total hip arthroplasty.

Authors:  L Lidgren; B Nordström
Journal:  Arch Orthop Trauma Surg       Date:  1979-06-29
View more
  4 in total

1.  The suppression of heterotopic ossification after total hip arthroplasty.

Authors:  H J Reis; W Küsswetter; T Schellinger
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

2.  [Prevention of thromboembolism in para-articular femoral fractures of the hip--results of a prospective randomized study of heparin-DHE and ASS-DHE].

Authors:  E Orthner; H Hertz; O Kwasny; R Maier; F Zekert; M Schemper; R Höfer; H Bergmann; E Havlick; F X Wohlzogen
Journal:  Unfallchirurgie       Date:  1990-06

3.  Effects of acetylsalicylic acid on heterotopic bone resorption and formation in rats.

Authors:  L F Solheim; H Rönningen; N Langeland
Journal:  Arch Orthop Trauma Surg       Date:  1986

Review 4.  Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis.

Authors:  Shun-Li Kan; Bo Yang; Guang-Zhi Ning; Ling-Xiao Chen; Yu-Lin Li; Shi-Jie Gao; Xing-Yu Chen; Jing-Cheng Sun; Shi-Qing Feng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.